Cargando…
Lenalidomide-Induced Diffuse Alveolar Hemorrhage in Patient With Multiple Myeloma
We present a case of multiple myeloma that was treated with a regimen that included lenalidomide. Lenalidomide, a thalidomide analog, is an immunomodulatory drug created synthetically by changing the chemical makeup of thalidomide to increase efficacy and lessen negative effects. It has been authori...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491948/ https://www.ncbi.nlm.nih.gov/pubmed/37692720 http://dx.doi.org/10.7759/cureus.43250 |
_version_ | 1785104170950328320 |
---|---|
author | Qanash, Sultan Alamoudi, Sameer Alsuraihi, Anas Jafri, Asif Malakah, Manar A Baghlaf, Bayan Alamoudi, Mulukah Althobaiti, Mohammad M |
author_facet | Qanash, Sultan Alamoudi, Sameer Alsuraihi, Anas Jafri, Asif Malakah, Manar A Baghlaf, Bayan Alamoudi, Mulukah Althobaiti, Mohammad M |
author_sort | Qanash, Sultan |
collection | PubMed |
description | We present a case of multiple myeloma that was treated with a regimen that included lenalidomide. Lenalidomide, a thalidomide analog, is an immunomodulatory drug created synthetically by changing the chemical makeup of thalidomide to increase efficacy and lessen negative effects. It has been authorized for the treatment of relapsed or resistant multiple myeloma. In the case discussed in this report, the patient's lenalidomide dosage was changed to account for her renal impairment. Regardless of this adjustment of the dose, the patient presented with lung infiltrates, hemoptysis, and fever. Unfortunately, she was diagnosed with diffuse alveolar hemorrhage (DAH) secondary to lenalidomide after excluding other causes of hemoptysis. To the best of our knowledge, we believe this is the first case of DAH reported with lenalidomide in Saudi Arabia, which also discusses the possible therapeutic options for such presentations. |
format | Online Article Text |
id | pubmed-10491948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-104919482023-09-10 Lenalidomide-Induced Diffuse Alveolar Hemorrhage in Patient With Multiple Myeloma Qanash, Sultan Alamoudi, Sameer Alsuraihi, Anas Jafri, Asif Malakah, Manar A Baghlaf, Bayan Alamoudi, Mulukah Althobaiti, Mohammad M Cureus Oncology We present a case of multiple myeloma that was treated with a regimen that included lenalidomide. Lenalidomide, a thalidomide analog, is an immunomodulatory drug created synthetically by changing the chemical makeup of thalidomide to increase efficacy and lessen negative effects. It has been authorized for the treatment of relapsed or resistant multiple myeloma. In the case discussed in this report, the patient's lenalidomide dosage was changed to account for her renal impairment. Regardless of this adjustment of the dose, the patient presented with lung infiltrates, hemoptysis, and fever. Unfortunately, she was diagnosed with diffuse alveolar hemorrhage (DAH) secondary to lenalidomide after excluding other causes of hemoptysis. To the best of our knowledge, we believe this is the first case of DAH reported with lenalidomide in Saudi Arabia, which also discusses the possible therapeutic options for such presentations. Cureus 2023-08-09 /pmc/articles/PMC10491948/ /pubmed/37692720 http://dx.doi.org/10.7759/cureus.43250 Text en Copyright © 2023, Qanash et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Oncology Qanash, Sultan Alamoudi, Sameer Alsuraihi, Anas Jafri, Asif Malakah, Manar A Baghlaf, Bayan Alamoudi, Mulukah Althobaiti, Mohammad M Lenalidomide-Induced Diffuse Alveolar Hemorrhage in Patient With Multiple Myeloma |
title | Lenalidomide-Induced Diffuse Alveolar Hemorrhage in Patient With Multiple Myeloma |
title_full | Lenalidomide-Induced Diffuse Alveolar Hemorrhage in Patient With Multiple Myeloma |
title_fullStr | Lenalidomide-Induced Diffuse Alveolar Hemorrhage in Patient With Multiple Myeloma |
title_full_unstemmed | Lenalidomide-Induced Diffuse Alveolar Hemorrhage in Patient With Multiple Myeloma |
title_short | Lenalidomide-Induced Diffuse Alveolar Hemorrhage in Patient With Multiple Myeloma |
title_sort | lenalidomide-induced diffuse alveolar hemorrhage in patient with multiple myeloma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491948/ https://www.ncbi.nlm.nih.gov/pubmed/37692720 http://dx.doi.org/10.7759/cureus.43250 |
work_keys_str_mv | AT qanashsultan lenalidomideinduceddiffusealveolarhemorrhageinpatientwithmultiplemyeloma AT alamoudisameer lenalidomideinduceddiffusealveolarhemorrhageinpatientwithmultiplemyeloma AT alsuraihianas lenalidomideinduceddiffusealveolarhemorrhageinpatientwithmultiplemyeloma AT jafriasif lenalidomideinduceddiffusealveolarhemorrhageinpatientwithmultiplemyeloma AT malakahmanara lenalidomideinduceddiffusealveolarhemorrhageinpatientwithmultiplemyeloma AT baghlafbayan lenalidomideinduceddiffusealveolarhemorrhageinpatientwithmultiplemyeloma AT alamoudimulukah lenalidomideinduceddiffusealveolarhemorrhageinpatientwithmultiplemyeloma AT althobaitimohammadm lenalidomideinduceddiffusealveolarhemorrhageinpatientwithmultiplemyeloma |